Skip to main content
. Author manuscript; available in PMC: 2010 Aug 25.
Published in final edited form as: Genes Immun. 2006 Jun 15;7(6):468–475. doi: 10.1038/sj.gene.6364317

Table 4.

Results of transmission disequilibrium testing for transmission of the CCR5-Δ32 allele

JRA phenotype Number of families Number of affected CCR5 WT CCR5-Δ 32 P1
Observed Expected Observed Expected
All JRA 697 819 1493 1486 145 152 0.36
Pauciarticular 346 409 746 738 72 80 0.14
Polyarticular 283 303 543 547 63 59 0.47
Systemic 104 104 198 194 10 14 0.08
Early onset2 405 459 850 839 68 79 0.05
Late onset2 327 355 634 637 76 74 0.66
Unaffected siblings3 348 5483 984 989 112 107 0.46
1

P values were calculated by bootstrap simulation based on 10,000 samples.

2

Early onset was defined as onset before age 6, and late onset was defined as onset at 6 years or later

3

Children with JRA were excluded from this analysis, and only families with unaffected siblings of children with JRA were used for this analysis.